about
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are meta...
Read More
15.98
0.96
(6.39%)
806.2K
XNAS Volume
XNAS 22 Jan, 2026 4:19 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Regenxbio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..